Loading clinical trials...
Loading clinical trials...
Phase 3 Study of Efficacy and Safety of Topical E-101 Solution to Prevent Incisional Infections Among Colorectal Surgery Patients (Triple IN Study --Inhibition of Incisional Infections)
Conditions
Interventions
E-101 Solution 300 GU/ml
Saline solution
Locations
39
United States
University of South Alabama Medical Center
Mobile, Alabama, United States
University of Southern California
Los Angeles, California, United States
Stanford University Medical Center
Stanford, California, United States
Sheridan Clinical Research, Inc.
Sunrise, Florida, United States
University of South Florida/Tampa General Hospital
Tampa, Florida, United States
Cleveland Clinic Florida
Weston, Florida, United States
Start Date
January 10, 2013
Primary Completion Date
October 14, 2015
Completion Date
October 14, 2015
Last Updated
February 10, 2021
NCT05488340
NCT06237452
NCT06631287
NCT07179159
NCT04142047
NCT07220109
Lead Sponsor
Excited States, LLC
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions